Literature DB >> 24672670

Recurrence of primary sclerosing cholangitis after liver transplantation - The Hungarian experience.

Fanni Gelley, Gergely Zádori, Dénes Görög, László Kóbori, Imre Fehérvári, György Gámán, Zsuzsanna Gerlei, Péter Nagy, Enikő Sárváry, Balázs Nemes.   

Abstract

INTRODUCTION: Recurrence of primary sclerosing cholangitis (rPSC) after liver transplantation (OLT) significantly affects long-term graft survival. We aimed to evaluate the incidence of rPSC and clinical data of these patients in Hungary. PATIENTS AND METHODS: We retrospectively analyzed data of 511 whole liver transplantations from 1995 to 2011. During the study period, 49 OLTs were performed in 43 adult patients with end-stage PSC (10%).
RESULTS: Out of 49 OLT, 24 cases were excluded, rPSC was diagnosed in six patients (12%). Patients with rPSC had significantly higher mortality (p = 0.009) and graft loss (p = 0.009) in comparison to patients without recurrent disease. Younger recipient age, higher donor BMI was observed in the rPSC group. One patient was diagnosed with de novo IBD, the remaining five patients had worsening IBD activity in the posttransplant period. PreOLT colectomy was performed in 21% of the control and none of the rPSC group. PostOLT colectomy was performed in two rPSC patients due to severe therapy resistant colitis.
CONCLUSIONS: Recurrent PSC significantly affects long-term mortality and graft loss. Younger age at OLT, higher donor BMI and severe active IBD may be associated with PSC recurrence. PreOLT total colectomy might have protective effect against rPSC.

Entities:  

Keywords:  disease recurrence; inflammatory bowel disease; liver transplantation; primary sclerosing cholangitis

Year:  2014        PMID: 24672670      PMCID: PMC3955810          DOI: 10.1556/IMAS.6.2014.1.2

Source DB:  PubMed          Journal:  Interv Med Appl Sci        ISSN: 2061-1617


  10 in total

1.  Risk factors for recurrence of primary sclerosing cholangitis of liver allograft.

Authors:  Alonso Vera; Shazma Moledina; Bridget Gunson; Stefan Hubscher; Darius Mirza; Simon Olliff; James Neuberger
Journal:  Lancet       Date:  2002-12-14       Impact factor: 79.321

Review 2.  Immunology of the gut and liver: a love/hate relationship.

Authors:  D H Adams; B Eksteen; S M Curbishley
Journal:  Gut       Date:  2008-01-18       Impact factor: 23.059

Review 3.  Update on primary sclerosing cholangitis.

Authors:  Tom H Karlsen; Erik Schrumpf; Kirsten M Boberg
Journal:  Dig Liver Dis       Date:  2010-02-20       Impact factor: 4.088

4.  Activity of ulcerative colitis before and after liver transplantation in primary sclerosing cholangitis: the Hungarian experience.

Authors:  F Gelley; P Miheller; A Péter; G Telkes; B Nemes
Journal:  Transplant Proc       Date:  2012-09       Impact factor: 1.066

5.  Recurrence of primary sclerosing cholangitis following liver transplantation.

Authors:  I W Graziadei; R H Wiesner; K P Batts; P J Marotta; N F LaRusso; M K Porayko; J E Hay; G J Gores; M R Charlton; J Ludwig; J J Poterucha; J L Steers; R A Krom
Journal:  Hepatology       Date:  1999-04       Impact factor: 17.425

6.  Recurrence of primary sclerosing cholangitis in patients after liver transplantation.

Authors:  U Ołdakowska-Jedynak; M Nowak; K Mucha; B Foroncewicz; P Nyckowski; K Zieniewicz; B Ziarkiewicz-Wróblewska; W Patkowski; B Górnicka; A Paczkowska; B Michałowicz; T Pilecki; J Pawlak; M Krawczyk; L Paczek
Journal:  Transplant Proc       Date:  2006 Jan-Feb       Impact factor: 1.066

Review 7.  Recurrence and rejection in liver transplantation for primary sclerosing cholangitis.

Authors:  Bjarte Fosby; Tom H Karlsen; Espen Melum
Journal:  World J Gastroenterol       Date:  2012-01-07       Impact factor: 5.742

8.  Liver transplantation for primary sclerosing cholangitis: a long-term clinicopathologic study.

Authors:  Urmila Khettry; Andrew Keaveny; Atoussa Goldar-Najafi; W David Lewis; Elizabeth A Pomfret; James J Pomposelli; Roger L Jenkins; Fredric D Gordon
Journal:  Hum Pathol       Date:  2003-11       Impact factor: 3.466

9.  Clinically recurrent primary sclerosing cholangitis following liver transplantation: a time course.

Authors:  Jeffrey Campsen; Michael A Zimmerman; James F Trotter; Michael Wachs; Thomas Bak; Tracy Steinberg; Igal Kam
Journal:  Liver Transpl       Date:  2008-02       Impact factor: 5.799

10.  A re-evaluation of the risk factors for the recurrence of primary sclerosing cholangitis in liver allografts.

Authors:  Edward Alabraba; Peter Nightingale; Bridget Gunson; Stefan Hubscher; Simon Olliff; Darius Mirza; James Neuberger
Journal:  Liver Transpl       Date:  2009-03       Impact factor: 5.799

  10 in total
  5 in total

Review 1.  Role of colectomy in preventing recurrent primary sclerosing cholangitis in liver transplant recipients.

Authors:  Bettina M Buchholz; Panagis M Lykoudis; Reena Ravikumar; Joerg M Pollok; Giuseppe K Fusai
Journal:  World J Gastroenterol       Date:  2018-07-28       Impact factor: 5.742

2.  Differences in Phenotypes and Liver Transplantation Outcomes by Age Group in Patients with Primary Sclerosing Cholangitis.

Authors:  Jacqueline B Henson; Yuval A Patel; Julius M Wilder; Jiayin Zheng; Shein-Chung Chow; Lindsay Y King; Andrew J Muir
Journal:  Dig Dis Sci       Date:  2017-04-08       Impact factor: 3.199

3.  Systematic review with meta-analysis: risk factors for recurrent primary sclerosing cholangitis after liver transplantation.

Authors:  Iris C Steenstraten; Kerem Sebib Korkmaz; Palak J Trivedi; Akin Inderson; Bart van Hoek; Mar D M Rodriguez Girondo; P W Jeroen Maljaars
Journal:  Aliment Pharmacol Ther       Date:  2019-02-10       Impact factor: 8.171

Review 4.  Autoimmune Liver Disease Post-Liver Transplantation: A Summary and Proposed Areas for Future Research.

Authors:  Catherine Edmunds; Udeme D Ekong
Journal:  Transplantation       Date:  2016-03       Impact factor: 4.939

Review 5.  Extraintestinal Manifestations of Inflammatory Bowel Disease: Current Concepts, Treatment, and Implications for Disease Management.

Authors:  Gerhard Rogler; Abha Singh; Arthur Kavanaugh; David T Rubin
Journal:  Gastroenterology       Date:  2021-08-03       Impact factor: 22.682

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.